Rare diseases
Investigational molecules
Locations
Testing dapagliflozin to slow kidney function decline in patients with autosomal dominant polycystic kidney disease
GermanyVorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy
GermanyTesting dehydroepiandrosterone combined with standard antidepressants for patients with treatment-resistant depression
GermanyTesting trifluridine, tipiracil and nanoliposomal irinotecan combination for patients with bile duct or gallbladder cancer after previous treatment
GermanyA study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer
GermanyTesting WIN378 Safety and Effects in Adults with Moderate or Severe Asthma
GermanyStudy of axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments
GermanyStudy of depemokimab to improve airway function in patients with type 2 eosinophilic asthma
GermanyStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
GermanyStudy of oral rilzabrutinib for adults with immune thrombocytopenia who did not respond to first-line treatment
GermanyStudy of budesonide, glycopyrronium and formoterol inhaler to evaluate heart and lung function in patients with chronic obstructive pulmonary disease and hyperinflation
GermanyComparing brincidofovir and cidofovir for treating adenovirus infection in children and adults after stem cell transplantation
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
